A Single Center, Double Blind, Randomized Crossover Study Evaluating the Bioequivalence of VIAject7 Compared to VIAject25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus.
Phase of Trial: Phase I/II
Latest Information Update: 15 Mar 2012
At a glance
- Drugs Insulin; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Biodel
- 15 Mar 2012 Planned patient number 44 added as reported by EudraCT.
- 01 Mar 2012 Results published in Diabetes, Obesity and Metabolism.
- 15 Nov 2010 New trial record